Brilliant Blue G Recalled Amid Links To Fungal Endophthalmitis

Ocular Surgery News

The U.S. Food and Drug Administration is recommending immediate quarantine and return of brilliant blue G ophthalmic solution compounded at a Florida pharmacy after receiving reports of fungal endophthalmitis in patients who were treated with the solution during eye surgery, according to a release.
  • <<
  • >>

Comments